Butylscopolamine Bromide

丁溴东莨菪碱

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameButylscopolamine Bromide
Drug Alias NameHyoscine Butylbromide溴化N-正丁基东莨菪碱BuscapinaBuscopan
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsGastrospasmVisceral spasmsNausea +[10] 
Global Approved IndicationsGastrospasmVisceral spasmsNausea +[6] 
Approved Indications in ChinaGastrospasmSpasmAnesthesia
Original Approved Country/TerritoryGermany
Original Approved Date1951/01/01
Country/TerritoryCanadaUnited StatesGermany +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChengdu First Pharmaceutical Co Ltd
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgLawson Health Research InstituteBoehringer Ingelheim Shanghai Pharmaceuticals Co Ltd +[4] 
Active IndicationsGastrospasmVisceral spasmsNausea +[6] 
Inactive IndicationsAbdomen, AcuteAbdominal PainPain +[4] 

Other Information

ATC CodeA03BB01
Related LinksWikipediaDrugBankKEGG